Sunny Balwani

Ramesh Balwani was born in Pakistan to a Sindhi family.[1][6] The family eventually moved to India "because being a Hindu in a mostly all-Muslim country of Pakistan was very difficult" according to Balwani's personal lawyer.[1] Later they immigrated to the United States. In 1986, Balwani began undergraduate studies at the University of Texas at Austin where he was a member of the Pakistani Students Association.[7][8] He received an undergraduate degree in information systems.[8]

According to research by The New York Times, it is unknown when, or why, he took the nickname "Sunny". In official documents from the late 1990s, and on divorce papers from 2002, he was known as Ramesh, his given name. By 2012, he was signing papers at Theranos as Sunny Balwani.[9]

Balwani worked for Lotus Software and Microsoft before 1998, when he helped to create CommerceBid,[10] a software development company that helped businesses buy and sell items over the burgeoning Internet.[8] In 1999, the company was purchased by Commerce One, another business development software company with a high valuation. The buyout was done entirely with stock,[8] and Balwani joined the board of the new company. In July 2000, Balwani sold his shares in Commerce One, netting nearly $40 million shortly before the company went out of business, just before the dot com bubble burst.[8][11] He later went back to school and received a Master of Business Administration from the University of California, Berkeley in 2003.[8] He spent another four years in a computer science graduate program at Stanford University, but dropped out in 2008.[8]

While enrolled at Berkeley, Balwani, who was 37 at the time, met Elizabeth Holmes, who was 18 and in her senior year of high school.[11] Holmes pursued an undergraduate degree in chemical engineering at Stanford,[11] but later dropped out to focus full-time on Theranos.[12]

Theranos Logo

Balwani joined Theranos in 2009. He ran the company's day-to-day operations as its president.[13] He had no training in biological sciences or medical devices,[13] which became an issue due to the absence of medical experts on the company's board of directors and Balwani's behavior. He was described by former Theranos employees as overbearing, uncompromising and so concerned about industrial espionage that he verged on paranoia.[11]

Within Theranos, Balwani was known for using technical terms he seemingly did not understand in what others believed were attempts to appear more knowledgeable.[11] Balwani at one point claimed "This invention [the Edison blood testing device] is going to be way up there, um, with-- with the discovery of antibiotics."[13] He once misheard "end effector" (the claw or other device at the end of an automated robot's arm) as "endofactor" (a nonsense word) and repeated the error throughout a meeting, furthermore not noticing when "Endofactor" was subsequently used as a prank in a PowerPoint presentation.[11]

The Wall Street Journal reported in October 2015 that the Edison blood testing device by Theranos produced inaccurate medical diagnoses and results.[14] Edison machines frequently failed quality-control checks and produced widely varying results, a finding that was corroborated in a report released in March 2016 by the federal Centers for Medicare and Medicaid Services (CMS).[15] In April 2016, Theranos told regulators it had voided all test results from Edison machines for 2014 and 2015, as well as some other tests it ran on conventional machines.[15]

In January 2016, the CMS sent a warning letter to Theranos after inspecting its Newark, California, laboratory.[16] CMS regulators proposed a two-year ban on Balwani from owning or operating a blood lab after the company had not fixed problems within its California lab in March 2016.[17]

The other charges of fraud against Theranos include claiming the company's technology was being used by the U.S. Department of Defense in combat situations despite never having been used.[18]

Another false claim included claiming a $100 million revenue stream in 2014 that was actually $100,000.[19]

He was married to Japanese artist Keiko Fujimoto.[11] Fujimoto and Balwani lived in San Francisco before their divorce in December 2002.[27]

Balwani was in a romantic relationship with Elizabeth Holmes during his tenure at Theranos.[28][29] Holmes met him in 2002 at age 18, while still in school. He was 19 years older than Holmes and married at the time.[28] Their relationship was not disclosed to their Theranos investors.[30] During her trial, Holmes testified that she had been raped while she was a student at Stanford and that she had sought solace from Balwani in the aftermath of the incident.[31][32] She also claimed that during her romantic relationship with Balwani, which lasted more than a decade, he was a very controlling figure and that he berated and sexually abused her.[32][31] In her court testimony, Holmes stated that Balwani wanted to "kill the person" she was and make her into a "new Elizabeth".[32] However, she later testified that Balwani had not forced her to make the false statements to investors, business partners, journalists and company directors that had been described in the case.[33] In court filings, Balwani and his ex-wife Fujimoto have "categorically" denied abuse allegations, calling them "false and inflammatory."[34]

Balwani was portrayed by Naveen Andrews in the 2022 miniseries The Dropout, which documented his relationship with Holmes and his role within Theranos.[35]

• "(video) Ramesh Balwani gives presentation. Begins at 1:20". Senate Health and Human Services, AZ State Government. March 12, 2014. Archived from the original on 2018-12-14. In the archive video, click the blank video screen to begin playing and on the sound-bar to enable sound.